Watch one brand's lines get read, flagged, reworded to the strongest the standard allows, signed and recorded, then watched weekly on monitoring. See what each step protects: the listing, the ads, the payouts and your rank.
We review the marketing claims, not the formulation.
Check one listing freeDrag to turn it. Illustrative brand.
Treats insomnia, naturally.
Insomnia is a named sleep disorder, so the line reads as a drug claim. Source: Marketplace listing, bullet 2.
Clinically proven deep sleep.
Proven is an absolute. It needs strong evidence on the finished product. Source: Product page, headline.
Calms anxiety so you can drift off.
Anxiety is a recognised disease. Naming it creates a drug claim. Source: Social ad, primary text.
Deep sleep that works in 3 days.
A time-to-result claim needs trial data on the finished product. Source: A+ content block, module 2.
Ruled. Signed. Still selling.
We review the marketing claims, not the formulation.
The audit is five days of reading. What it is bought for is everything below, none of which arrives as a fine.
A suppressed ASIN earns nothing while it is down, and the way back is an appeal built from evidence you either have or do not.
A processor review puts a reserve on the account. The revenue is yours and you still cannot spend it, and the reviewer wants documentation, not an explanation.
A restricted ad account can end paid traffic the day it happens. Google’s strikes apply to the account, not the ad: an account on hold cannot run any ads.
Claim exposure is a diligence line. An acquirer prices what it cannot verify, and a signed file is the difference between a discount and a clean close.
Every failing line comes back rewritten to keep the promise that sells. The point is rarely to say less.
The claims that passed, in writing, so the next campaign does not reopen what the audit closed.
The one number that tells you whether this is urgent for you or merely tidy.
Remove what takes revenue away. Keep every line that earns it.
The FDA, the FTC and Health Canada write the rules. Every gatekeeper reads them. Enforcement arrives late, and in public. We apply the same rules first, in private, on your side.
The platforms now read claims with AI, and the machines keep getting better. Amazon’s 2025 Trustworthy Shopping report describes AI scanning billions of attempted changes to product detail pages daily. Google says it stopped over 99% of policy-violating ads before they ran in 2025, with Gemini-powered tools. Amazon’s shopping assistant, renamed from Rufus to Alexa for Shopping in May 2026, answers shoppers from your listing details. Never flagged doesn’t mean cleared. It means no machine has acted yet.
Most brands hedge into language so soft it converts nothing. A minority overreach into claims that draw enforcement. The permitted middle is wider than either group assumes, and it is where the revenue is.
The middle column is not defensive spend. It is claim strength you were already entitled to and were not using, applied to the copy that does your selling.
The review is external and read-only. You hand us URLs. We read every claim a regulator, platform or acquirer would.
Title, bullets, A+ modules and backend keywords, every claim ruled and rewritten to survive Amazon’s automated review.
Claims that hold on your own site, read the way a regulator or plaintiff reads them.
Creative checked against Meta and Google health policies before it goes to review.
Welcome and cart emails too. The FTC treats them as advertising.
Keyword and meta copy that ranks, disease claims out.
ChatGPT, Claude, Gemini, Perplexity, Grok and Amazon’s Alexa for Shopping (formerly Rufus), asked as a shopper would, plus the strongest allowed wording worth quoting.
Label and carton claims checked before the print run, with placement for our seal ready if you pass.
A clear do-say list under FTC endorsement rules, so creators’ words never become your violation.
The audit is built to be safe to commission. It runs entirely on what the public can already see, and it is reported to you alone. Every audit runs under our confidentiality terms, and a mutual NDA is available to sign before you send us anything.
Every finding is rated, cited and rewritten to the strongest wording the standard allows. Critical is the class that can draw warning letters and takedowns. Fix those first.
“Cures anxiety,” “treats insomnia.” The claims that turn a supplement into an unapproved drug and can draw FDA warning letters.
“Clinically proven,” “#1 doctor recommended.” Prove it on demand or remove it: FTC substantiation territory.
“GMP certified” with no certificate on file, softened claims that still imply outcomes. Fix in the next content cycle.
A findings file built to be handed onward: to your copywriter to fix, to counsel to rely on, to a platform appeal or an acquirer’s data room as-is.
What was read, when, under which rule sets, and the terms it was ruled under.
Your risk score and where you sit against every ruled listing in your category.
Every finding in one table: severity, family, surface, statute. Your triage list.
Each quoted verbatim, cited to the rule it breaches, rated, and explained in plain language.
The strongest line the standard allows for every finding, written to keep the promise customers respond to.
What six AI assistants say about your brand, flagged where they repeat your risky claims.
The reviewing pharmacist’s signature, licence registration on file, and the seal eligibility verdict.
After your rewrites go live we re-run the scan against the same standards, included, and issue the updated score.
Scope confirmed in writing. We collect nothing but URLs. No scoping call required, and $500 starts it.
The engine reads every claim across your listing, A+ content, site, ads and emails, and rules each against all 109 standards.
The engine proposes the severity and cites the statute or policy each finding breaches. Every finding is reviewed and signed by a licensed pharmacist, who can change the severity or send a finding back. Every finding gets a paste-ready rewrite at the strongest wording the standard allows, so it keeps the promise customers respond to.
The complete findings file: severity-rated, statute-cited, pharmacist signed. If we find nothing Critical, we say so in writing. The balance is due on delivery.
Once your rewrites go live, we re-run the scan against the same standards and issue the updated score, included.
Send your URLs. No scoping call required. Not ready? Check one listing free first and see a real finding on your own copy.
Supplement claims review. Every public claim ruled against 109 published standards, rewritten to the rules and signed by a licensed pharmacist.